Arlene Morris
CIK 1362520 · CEO · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$566.9K
Companies
12
Total Filings
80
Lifetime Open-Market Net
-$16.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| COGT | Director | — | $33.10 | — | $0 | 6 | 2026-06-11 |
| PTN | Director | 41,580 | $13.61 | $565.7K | $28.7K | 16 | 2025-12-11 |
| VRDN | Director | — | $16.35 | — | $0 | 6 | 2025-07-02 |
| EWTX | Director | — | $34.83 | — | $0 | 3 | 2025-06-18 |
| VIVE | Director | 2,482 | $0.00 | $0 | $0 | 13 | 2023-01-05 |
| Cogent Biosciences, Inc. (UMRX) Delisted | Director | — | — | — | $0 | 2 | 2020-06-11 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | Director | — | — | — | $0 | 3 | 2017-11-07 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | Director | — | $0.03 | — | $0 | 1 | 2016-05-20 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Director | — | — | — | $0 | 2 | 2016-03-08 |
| MNOV | Director | 1,000 | $1.23 | $1.2K | -$28.9K | 7 | 2013-05-23 |
| AFFYMAX INC (AFFY) Delisted | CEO | 75,000 | — | — | -$16.32M | 18 | 2010-09-24 |
Recent Filings · Page 4 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-27 | VIVE | Grant (A) | — | $0 | EDGAR |
| 2019-07-29 | Cogent Biosciences, Inc. (UMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-26 | PTN | Grant (A) | +32,000 | $0 | EDGAR |
| 2019-06-21 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-31 | VIVE | Grant (A) | — | $0 | EDGAR |
| 2018-11-21 | PTN | Buy (P) | +12,000 | $8.2K | EDGAR |
| 2018-10-25 | VIVE | Grant (A) | — | $0 | EDGAR |
| 2018-06-28 | PTN | Grant (A) | +28,000 | $0 | EDGAR |
| 2018-06-28 | Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-23 | VIVE | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.